201 related articles for article (PubMed ID: 9201724)
1. [A new approach to innovating selective anxiolytics: pharmacological profile of a novel 5-HT1A agonist (tandospirone)].
Sasa M
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr; 17(2):53-9. PubMed ID: 9201724
[TBL] [Abstract][Full Text] [Related]
2. Serotonergic mechanisms in anxiolytic effect of tandospirone in the Vogel conflict test.
Shimizu H; Tatsuno T; Tanaka H; Hirose A; Araki Y; Nakamura M
Jpn J Pharmacol; 1992 May; 59(1):105-12. PubMed ID: 1354771
[TBL] [Abstract][Full Text] [Related]
3. Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions.
Matsubara K; Shimizu K; Suno M; Ogawa K; Awaya T; Yamada T; Noda T; Satomi M; Ohtaki K; Chiba K; Tasaki Y; Shiono H
Brain Res; 2006 Sep; 1112(1):126-33. PubMed ID: 16884702
[TBL] [Abstract][Full Text] [Related]
4. Tandospirone-induced K+ current in acutely dissociated rat dorsal raphe neurones.
Jin YH; Akaike N
Br J Pharmacol; 1998 Jul; 124(5):897-904. PubMed ID: 9692774
[TBL] [Abstract][Full Text] [Related]
5. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
7. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
[TBL] [Abstract][Full Text] [Related]
8. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
Evans SM; Troisi JR; Griffiths RR
J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice.
Biała G
Pol J Pharmacol; 1998; 50(2):117-24. PubMed ID: 9798263
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
11. Effects of tandospirone, a 5-HT1A receptor-related anxiolytic, on the pressor response elicited by stimulation of the posterior hypothalamus in cats.
Tsuji R; Ohno Y; Hirose A; Shimizu H; Tanaka H; Nakamura M
Arch Int Pharmacodyn Ther; 1991; 311():131-43. PubMed ID: 1686389
[TBL] [Abstract][Full Text] [Related]
12. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
[TBL] [Abstract][Full Text] [Related]
13. Behavioral studies of serotonin receptor agonists as antidepressant drugs.
Lucki I
J Clin Psychiatry; 1991 Dec; 52 Suppl():24-31. PubMed ID: 1684363
[TBL] [Abstract][Full Text] [Related]
14. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Tatarczyńska E; Nikiforuk A; Chojnacka-Wójcik E; Pawłowski M; Martinez J
Bioorg Med Chem; 2007 Apr; 15(8):2907-19. PubMed ID: 17321139
[TBL] [Abstract][Full Text] [Related]
15. Effects of tandospirone, a 5-HT1A receptor-related anxiolytic, on daytime sleepiness and psychomotor functions: a comparative double-blind study with diazepam.
Suzuki M; Uchiumi M; Murasaki M
Yakubutsu Seishin Kodo; 1993 Aug; 13(4):213-24. PubMed ID: 7901952
[TBL] [Abstract][Full Text] [Related]
16. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
17. The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats.
Kasahara K; Hashimoto S; Hattori T; Kawasaki K; Tsujita R; Nakazono O; Takao K; Kawakubo H; Nagatani T
J Pharmacol Sci; 2015 Jan; 127(1):109-16. PubMed ID: 25704026
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic localization and pharmacological characterization of [3H]tandospirone binding sites in the rat brain.
Tanaka H; Shimizu H; Kumasaka Y; Hirose A; Tatsuno T; Nakamura M
Brain Res; 1991 Apr; 546(2):181-9. PubMed ID: 1648988
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonist.
Simiand J; Keane PE; Barnouin MC; Keane M; Soubrié P; Le Fur G
Fundam Clin Pharmacol; 1993; 7(8):413-27. PubMed ID: 7904976
[TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior.
Murata Y; Yanagihara Y; Mori M; Mine K; Enjoji M
J Affect Disord; 2015 Jul; 180():1-9. PubMed ID: 25879718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
